Accessibility Menu
Vireo Growth logo

Vireo Growth(OTC) VREOF

Market Cap$546.83MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)-92%
5 Year-75%
1 Year-50%
1 Month+12%
$10.60
+0.47%
+0.05Today
Vireo Growth last closing stock price
MetricPriceDate
Last closeUSD 10.602026-08-28
Vireo Growth stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-2.39%USD 10.862026-08-21
1 month+12.29%USD 9.442026-07-29
3 month-17.83%USD 12.902026-05-29
Year to date-42.35%USD 18.392025-12-31
1 year-49.52%USD 21.002025-08-28
3 year+178.87%USD 3.802023-08-29
5 year-75.12%USD 42.602021-08-27
Since inception-92.32%USD 138.012019-03-25

Vireo Growth Financials at a Glance

Market Cap

$546.83MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$511.67M

Net Income (TTM)

-$67.07M

EPS (TTM)

-$1.98

P/E Ratio

-5.36

Dividend

$0.00

Beta (Volatility)

0.87 (Low)

Price

$10.60

Volume

14,248

Open

$10.55

Previous Close

$10.60

Daily Range

$10.48 - $10.80

52-Week Range

$8.91 - $22.50

Estimated Earnings Date

Nov 11, 2026

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Vireo Growth

Vireo Growth Inc. is a cannabis company engaged in the cultivation, manufacturing, processing, and distribution of medical and adult-use cannabis products across several states in the U.S. The company operates a network of retail dispensaries and distributors, positioning itself as a key player in the growing cannabis market.

Products and Services
  • Medical and adult-use cannabis products
  • Retail dispensaries and distribution networks
  • Innovative cannabis product formulations
Growth Outlook
  • Revenue increased to $209.3 million in Q2 2026, up from $106.2 million in Q1 2026
  • Gross profit margin improved to 45.5% in Q2 2026
  • Expansion into new markets expected to drive future growth
Financial Highlights
  • Net income for Q2 2026 was -$97,460, showing a reduction in losses
  • Cash and cash equivalents stood at $103.1 million as of June 30, 2026
  • Operating cash flow of $2.4 million in Q2 2026 indicates operational efficiency
Vireo Growth Inc. has demonstrated significant revenue growth in recent quarters, with a notable increase from $106.2 million in Q1 2026 to $209.3 million in Q2 2026. This upward trend reflects the company's ability to capitalize on the expanding cannabis market. The gross profit margin also saw an improvement, reaching 45.5% in Q2 2026, indicating effective cost management and pricing strategies. Despite reporting a net loss of $97,460 in Q2 2026, the reduction in losses compared to previous quarters suggests a positive trajectory towards profitability. The company's cash position remains strong, with $103.1 million in cash and cash equivalents, providing a solid foundation for future investments and operational needs. The operational efficiency is further highlighted by the positive operating cash flow of $2.4 million in Q2 2026, which indicates that the company is generating cash from its core business activities. With plans for expansion into new markets, Vireo Growth Inc. is well-positioned to leverage its strengths and capitalize on the growing demand for cannabis products.
AI Generated • Aug 29, 2026

Industry

Pharmaceuticals

Employees

612

CEO

John Mazarakis, MBA

Headquarters

Minneapolis, MN 55402, US

VREOF Financials

Key Financial Metrics (TTM)

Gross Margin

48.64%

Operating Margin

1.35%

Net Income Margin

-13.11%

Return on Equity

-20.79%

Return on Capital

1.66%

Return on Assets

-5.27%

Earnings Yield

-18.66%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$546.83MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

51.59M

Volume

14.25K

Avg. Volume

22.47K

Financials (TTM)

Gross Profit

$248.87M

Operating Income

$6.91M

EBITDA

$47.87M

Operating Cash Flow

$26.16M

Capital Expenditure

-$143.68M

Free Cash Flow

-$117.52M

Cash & ST Invst.

$104.10M

Total Debt

$485.22M

Vireo Growth Performance Analysis

Vireo Growth annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 74,625,86737.1%
20232023-12-31USD 88,133,16318.1%
20242024-12-31USD 99,384,22112.8%
20252025-12-31USD 268,769,268170.4%
Vireo Growth sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3090.7%
Q42025-12-3114.0%
Q12026-03-311.6%
Q22026-06-3097.1%
Vireo Growth annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -9.9421.8%
20232023-12-31USD -5.67-43.0%
20242024-12-31USD -4.66-17.8%
20252025-12-31USD -2.78-40.3%
Vireo Growth sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-308.7%
Q42025-12-3128.1%
Q12026-03-315.2%
Q22026-06-3099.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$209.30M

+335.5%

Gross Profit

$95.30M

+366.7%

Gross Margin

45.53%

N/A

Market Cap

$546.83MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$893.51K

N/A

Employees

612

N/A

Net Income

-$97.46K

+99.3%

EBITDA

$19.00M

+4129.4%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$104.10M

+4.0%

Total Debt

$485.22M

+192.1%

Accounts Receivable

$87.00M

+145.9%

Inventory

$149.40M

+137.0%

Long Term Debt

$428.98M

+217.1%

Short Term Debt

$56.30M

+82.6%

Return on Assets

-5.27%

N/A

Return on Invested Capital

0.78%

N/A

Free Cash Flow

-$105.80M

-1100.3%

Operating Cash Flow

$2.40M

+149.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
INNPFINNOCAN PHARMA Corp
$1.62-6.90%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$217.55-0.05%
PCGPG&E
$16.60-0.08%
BITOProShares Trust - ProShares Bitcoin ETF
$10.45-0.03%
IRENIren
$35.45-0.13%

Questions About VREOF

What is the current price of Vireo Growth?

Vireo Growth is trading at $10.60 per share.

What is the 52-week range for Vireo Growth?

Over the past 52 weeks, Vireo Growth has traded between $8.91 and $22.50.

How much debt does Vireo Growth have?

As of the most recent reporting period, Vireo Growth reported total debt of $485.80M.

How much cash does Vireo Growth have on hand?

Vireo Growth reported $122.70M in cash and cash equivalents in its most recent financial results.

What is Vireo Growth’s dividend yield?

Vireo Growth does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.